SUNSHINE BIOPHARMA INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.93
-12.01%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-78.7%
3 months
-87.5%
6 months
-98.6%
1 year
-99.2%
Year to date
-98.8%
52-week range
$2.65 – $358.00
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$600K
P/E
-0.1
P/B
0
P/S
0
Revenue
$35.35M
Net income
-$5.83M
Diluted EPS
-203
Gross margin
30.30%
Net margin
-16.50%
Return on equity
-24.20%
Total debt
$678.34K
Cash
$14.03M
Free cash flow
-$5.45M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $9.26M | -$1.56M | 26.20% | -16.90% | -$924.99K |
| Mar 31, 2026 | $8.09M | -$1.24M | 27.00% | -15.40% | -$2.08M |
| Dec 31, 2025 | $8.58M | -$2.14M | 35.30% | -25.00% | -$1.63M |
| Sep 30, 2025 | $9.42M | -$883.82K | 32.60% | -9.40% | -$819.99K |
| Jun 30, 2025 | $9.41M | -$1.77M | 36.40% | -18.80% | -$1.38M |
| Mar 31, 2025 | $8.9M | -$1.18M | 30.70% | -13.30% | -$1.69M |
| Dec 31, 2024 | $9.59M | -$2.16M | 32.20% | -22.50% | -$3.94M |
| Sep 30, 2024 | $8.44M | -$1.2M | 34.00% | -14.20% | -$1.85M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent SBFM news
All market newsNo ticker-linked stories are in the current archive.